|4Dec 4, 5:55 PM ET

BRYCE RICHARD PAUL 4

4 · enGene Holdings Inc. · Filed Dec 4, 2023

Insider Transaction Report

Form 4
Period: 2023-11-30
BRYCE RICHARD PAUL
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-11-30+153,000153,000 total
    Exercise: $7.66Exp: 2033-11-30Common Shares (153,000 underlying)
Footnotes (1)
  • [F1]This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years.

Documents

1 file
  • 4
    form4.xmlPrimary